60 Participants Needed

Cognitive Training for Post-Transplant Cognitive Impairment

(cTAG Trial)

LH
NM
Overseen ByNoha M Sharafeldin, MD,MSc, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Alabama at Birmingham
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores whether a brain-training program called Lumosity can improve memory and thinking skills in individuals who have undergone a blood stem cell transplant. It also examines participants' interest in learning about their genetic risk for cognitive issues post-transplant. Two groups participate: one begins the Lumosity program immediately, while the other starts after three months. Eligible participants must have had a stem cell transplant at least three months prior, be in outpatient care, and have internet access. Participants should not have major neurological or psychiatric issues or have recently participated in a similar brain-training program. As an unphased trial, this study offers a unique opportunity to contribute to understanding cognitive recovery after stem cell transplants.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that the Lumosity program is safe for improving neurocognitive function in HCT survivors?

Research has shown that Lumosity, a brain training program, is generally safe for use. In past studies, participants engaged in various games and exercises on Lumosity to train their brains. These studies have not identified any major negative side effects from using the program.

For instance, one study tested Lumosity and found it helped maintain thinking skills without harming participants. Another study suggested that playing brain games like those in Lumosity might help slow mental decline in some areas, again without causing major problems.

Overall, the evidence indicates that Lumosity is well-tolerated by users. Participants in these studies did not report any serious issues from using the program. This suggests that Lumosity is a safe choice for those looking to improve or maintain their mental abilities.12345

Why are researchers excited about this trial?

Researchers are excited about using Lumosity for post-transplant cognitive impairment because it offers a non-pharmacological approach to improving cognitive function. Unlike standard treatments that may focus on medication to manage symptoms, Lumosity is a brain-training program that uses engaging games and exercises to potentially enhance memory, attention, and problem-solving skills. This method is appealing because it is user-friendly, accessible from home, and can be tailored to individual cognitive needs, providing a personalized experience that traditional treatments may lack.

What evidence suggests that the Lumosity program is effective for improving neurocognitive function in HCT survivors?

Research shows that brain training programs like Lumosity can enhance brain function. Studies have found that these computer-based exercises can slow mental decline, keeping the brain sharp. In similar situations, such as surgery, brain training has reduced issues like confusion and memory loss shortly after the operation. In this trial, one group of participants will begin the Lumosity program at enrollment, while another group will start three months later. Although specific data for hematopoietic cell transplantation (HCT) survivors is limited, these findings suggest that Lumosity might also improve brain function in HCT survivors.26789

Who Is on the Research Team?

NM

Noha Sharafeldin, MD, MSc, PhD

Principal Investigator

University of Alabama at Birmingham

Are You a Good Fit for This Trial?

This trial is for adults over 21 who had a bone marrow transplant at UAB, are 3-6 months post-transplant, and can use an internet-connected computer. It's not for those with neurological or major psychiatric disorders, significant sensory/motor issues, color blindness, or recent neuropsychological intervention.

Inclusion Criteria

Possess access to an internet-connected home computer
I am 3 to 6 months post bone marrow transplant and not hospitalized.
I am 21 years or older and had a stem cell transplant at UAB.
See 1 more

Exclusion Criteria

I have a history of color blindness.
I do not have a major neurological or psychiatric disorder, or significant hearing, vision, or movement issues.
You have received help from a mental health professional in the last 6 months.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in daily cognitive training using the Lumosity program for 12 weeks

12 weeks
Daily online sessions

Follow-up

Participants are monitored for changes in cognitive function and attitudes towards genetic information

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Lumosity
Trial Overview The study tests if the Lumosity cognitive training program helps improve brain function in people who've had a bone marrow transplant. Participants will either start training right away or be placed on a waitlist (control group) to compare results.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Group II: Wait List ControlActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alabama at Birmingham

Lead Sponsor

Trials
1,677
Recruited
2,458,000+

Published Research Related to This Trial

In a study of 157 kidney transplant recipients, objective cognitive assessment using the Montreal Cognitive Assessment (MoCA) was found to be more reliable than clinical perceptions from physicians and nurses in identifying cognitive impairment.
The study revealed that clinical perceptions had low accuracy, with only 66% sensitivity for physicians and 65% for nurses in detecting cognitive impairment, highlighting the need for standardized cognitive screening tools in transplant patients.
Discrepancies between Perceived and Measured Cognition in Kidney Transplant Recipients: Implications for Clinical Management.Gupta, A., Thomas, TS., Klein, JA., et al.[2022]
Cognitive impairments are common in organ transplant candidates and recipients, with some patients, especially frail individuals, continuing to experience these issues even after transplantation, indicating a need for ongoing assessment.
New assessment tools for cognitive impairments, particularly in liver transplant candidates, show promise for integration into clinical practice, but further research is needed to establish effective assessment and intervention strategies post-transplant.
Current recommendations regarding evaluation of cognitive functioning in organ transplant candidates.Jesse, MT., Haver, DB.[2023]
The culture-based virtual reality (VR) training program was found to be feasible and well-tolerated by patients with amnestic mild cognitive impairment (aMCI), with a high adherence rate of 91.55%.
Despite the program's feasibility, it did not lead to significant improvements in cognitive function as measured by various tests, including the Korean Mini-Mental State Examination and working memory assessments.
Feasibility and Tolerability of a Culture-Based Virtual Reality (VR) Training Program in Patients with Mild Cognitive Impairment: A Randomized Controlled Pilot Study.Park, JH., Liao, Y., Kim, DR., et al.[2020]

Citations

Cognitive Training for Post-Transplant Cognitive ImpairmentTrial Overview The study tests if the Lumosity cognitive training program helps improve brain function in people who've had a bone marrow transplant.
The effects of computerised cognitive training on post-CABG ...In pre-operative settings (non-cardiac patients), cognitive training has significantly reduced cognitive decline (1-week post-operatively)19 and delirium ...
Diet and Cognitive Training in Hematologic Cancer SurvivorsThe goal of this clinical trial is to examine feasibility of a cognitive intervention program in blood cancer survivors. The main questions it aims to ...
Published Papers - HCPBelow you'll find abstracts from published papers from our team and HCP collaborators, including observational studies regarding trends in Lumosity data.
Published PapersThis is a partial list of studies that directly demonstrate that computerized cognitive training can improve cognition.
A randomized controlled trial of brain training with non- ...This randomized controlled study (ClinicalTrials.gov NCT02007616) investigated the maintenance of training effects of 20 1-hr non-action video game training ...
'Brain games': Helpful tool or false promise?According to the company's literature, Lumosity offers a "personalized brain training program" and related assessment measures, as well as ...
Interventions Made to Preserve Cognitive Function Trial ...Intradialytic CT consists of playing brain games through Lumosity®, which is a web-based cognitive training program on a tablet PC for at least ...
Intradialytic Cognitive and Exercise Training May Preserve ...Preliminary findings of our pilot study suggested that cognitive decline in psychomotor speed and executive function is possibly prevented by intradialytic CT ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security